
### [Orphanet:650](http://www.orpha.net/ORDO/Orphanet_650)
**Label:** LCAT deficiency

**Subclasses:** [Orphanet:79292](http://www.orpha.net/ORDO/Orphanet_79292) (Fish-eye disease), [Orphanet:79293](http://www.orpha.net/ORDO/Orphanet_79293) (Familial LCAT deficiency), 

**Corr. equiv. classes:** [OMIM:136120](http://purl.obolibrary.org/obo/OMIM_136120), [Orphanet:79292](http://www.orpha.net/ORDO/Orphanet_79292), [Orphanet:79293](http://www.orpha.net/ORDO/Orphanet_79293), [OMIM:245900](http://purl.obolibrary.org/obo/OMIM_245900), 

**Class expressions from DL-Learner:**

- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0011492](http://purl.obolibrary.org/obo/HP_0011492) (Abnormality of corneal stroma) 75.00%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007957](http://purl.obolibrary.org/obo/HP_0007957) (Corneal opacity) 75.00%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007759](http://purl.obolibrary.org/obo/HP_0007759) (Opacification of the corneal stroma) 75.00%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0002155](http://purl.obolibrary.org/obo/HP_0002155) (Hypertriglyceridemia) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0011492](http://purl.obolibrary.org/obo/HP_0011492) (Abnormality of corneal stroma) 75.00%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0002155](http://purl.obolibrary.org/obo/HP_0002155) (Hypertriglyceridemia) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007957](http://purl.obolibrary.org/obo/HP_0007957) (Corneal opacity) 75.00%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0002155](http://purl.obolibrary.org/obo/HP_0002155) (Hypertriglyceridemia) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007759](http://purl.obolibrary.org/obo/HP_0007759) (Opacification of the corneal stroma) 75.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007759](http://purl.obolibrary.org/obo/HP_0007759) (Opacification of the corneal stroma) 75.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002155](http://purl.obolibrary.org/obo/HP_0002155) (Hypertriglyceridemia) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0011492](http://purl.obolibrary.org/obo/HP_0011492) (Abnormality of corneal stroma) 75.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002155](http://purl.obolibrary.org/obo/HP_0002155) (Hypertriglyceridemia) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007957](http://purl.obolibrary.org/obo/HP_0007957) (Corneal opacity) 75.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002155](http://purl.obolibrary.org/obo/HP_0002155) (Hypertriglyceridemia) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007759](http://purl.obolibrary.org/obo/HP_0007759) (Opacification of the corneal stroma) 75.00%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0007957](http://purl.obolibrary.org/obo/HP_0007957) (Corneal opacity) 72.86%
- [HP:0000481](http://purl.obolibrary.org/obo/HP_0000481) (Abnormality of the cornea) and [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) 72.86%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0004328](http://purl.obolibrary.org/obo/HP_0004328) (Abnormality of the anterior segment of the globe) 70.23%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe) 68.12%
- [HP:0003233](http://purl.obolibrary.org/obo/HP_0003233) (Decreased circulating high-density lipoprotein levels) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 68.12%


